Officials at Concept Life Sciences say the company’s headquarters is now one of the U.K.’s largest drug discovery research sites.

IGF2BP3 links cancer metabolism and RNA control, offering a potential new therapeutic target for blocking leukemia cell growth.

ADCs can potentially expand the range of effective therapies while minimizing toxicity to healthy tissues, especially in refractory cancer.

Consistently-sized nano-scale lipopolyplex nonviral vectors were created in a microfluidics system for DNA delivery.

This mechanism for conferring longevity across generations could also explain how other stress-adaptive traits are passed to offspring.

Proposed NIH funding cuts are a pressing concern when one considers the broader impacts of reduced research funding.

Whether you’re just starting your intensification journey or looking to scale it to the next level, this eBook offers the strategic foundation and operational perspective to help you move forward.

David Baker’s Nobel Prize-winning lab has designed protein on/off switches as a tool for tunable cancer immunotherapies and biosensors.

Researchers are now exploring how different types of repetitive DNA create genome instability and structurally variant chromosomes.

AMT-130 has been granted Breakthrough Therapy designation and Regenerative Medicine Advanced Therapy (RMAT) designation from the FDA.

U.K. scientists have used mass spectrometry to look in detail at how AAV release their genetic cargo when infecting host cells.